Forward Look

Medical oncologist Lola Fashoyin-Aje describes the Food and Drug Administration’s efforts to make clinical trials more inclusive.

by Erin O'Donnell

Forward Look

Results favor Enhertu for treating metastatic breast cancer that recurs or does not respond to first-line treatment.

by Kris Conner

Forward Look

Success of immune checkpoint inhibitors in clinical trials does not always carry over to patients in the clinic.

by Delia O'Hara

Forward Look

Artificial intelligence may help to classify colorectal polyps.

by Nancy Averett

Forward Look

Research suggests short bursts of intense calorie restriction could improve treatment response in patients with a range of cancers.

by Robin Donovan

Forward Look

Pilot program emphasizes standards to streamline patient care.

by Carolyn Bernhardt

A new report from the American Association for Cancer Research explores how the COVID-19 pandemic affected cancer patients, researchers and care providers.

by Eric Fitzsimmons

The Cancer Today editorial staff selects some of the most impactful reporting and essays of 2021.

by Cancer Today Staff

From the Editor-in-Chief

Data analysis platforms that map the cosmos are being applied to map the tumor microenvironment, an approach that could revolutionize cancer pathology.

by William G. Nelson, MD, PhD

When you are diagnosed with cancer, how can you be sure you're getting appropriate care?

by K.J. Bannan